NovAccess Global Inc.: NovAccess Global Launches Precision Medicine Division Using AI, Big Data and Predictive Technologies to Accelerate Personalized Healthcare Therapies

CLEVLAND, OH / ACCESSWIRE / June 1, 2023 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today announced the formation of its Precision

Related Keywords

Dwaink Irvin , ,Our Company ,Securities Exchange ,Predictive Technology ,Novaccess Global Inc ,Novaccess Global Inc View ,Darrow Associates ,Securities Exchange Commission ,Precision Medicine Division ,Novaccess Global ,Big Data ,Chief Executive Officer ,Access Global ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Relations Contact ,Novaccess ,Lobal ,Aunches ,Precision ,Medicine ,Division ,Sing ,Data ,Predictive ,Technologies ,Ccelerate ,Personalized ,Healthcare ,Therapies ,